24 results
8-K
EX-99.1
0628ri44lnzrdtlgm36t
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm
8-K
EX-1.1
2w6vnyah 7k
21 Jun 21
Entry into a Material Definitive Agreement
4:58pm
8-K
EX-99.1
kkhpqvmo ed
17 May 21
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
0kbn9m2hpocd r7fyfv
25 Mar 21
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
12:00am
8-K
EX-1.1
mn4mlbbdy
19 Feb 21
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-1.1
k8t7vp
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-1.1
w47vo0w vdtr4
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.1
dfmltx2lxl y5
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-10.1
4252 s897r7ew8
26 Dec 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
m9h1m vfnjcky
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-10.1
9rrqp2cf xt268
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am